Royalty Pharma plc (RPRX)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 12.39B |
| Enterprise value | 17.00B |
| Trailing P/E | 15.44 |
| Forward P/E | 9.13 |
| PEG ratio (5-yr expected) | 1.35 |
| Price/sales (ttm) | 7.37 |
| Price/book (mrq) | 1.91 |
| Enterprise value/revenue | 7.59 |
| Enterprise value/EBITDA | 12.40 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.47 |
| 52-week change 3 | -16.90% |
| S&P500 52-week change 3 | 28.04% |
| 52-week high 3 | 34.65 |
| 52-week low 3 | 25.92 |
| 50-day moving average 3 | 28.86 |
| 200-day moving average 3 | 28.56 |
Share statistics
| Avg vol (3-month) 3 | 2.62M |
| Avg vol (10-day) 3 | 2.73M |
| Shares outstanding 5 | 450.98M |
| Implied shares outstanding 6 | 597.44M |
| Float 8 | 387.82M |
| % held by insiders 1 | 13.40% |
| % held by institutions 1 | 71.12% |
| Shares short (30 Apr 2024) 4 | 13.75M |
| Short ratio (30 Apr 2024) 4 | 5.13 |
| Short % of float (30 Apr 2024) 4 | 3.17% |
| Short % of shares outstanding (30 Apr 2024) 4 | 3.05% |
| Shares short (prior month 28 Mar 2024) 4 | 12.39M |
Dividends & splits
| Forward annual dividend rate 4 | 0.84 |
| Forward annual dividend yield 4 | 3.06% |
| Trailing annual dividend rate 3 | 0.81 |
| Trailing annual dividend yield 3 | 2.97% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 45.51% |
| Dividend date 3 | 14 Jun 2024 |
| Ex-dividend date 4 | 16 May 2024 |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Mar 2024 |
Profitability
| Profit margin | 35.69% |
| Operating margin (ttm) | -12.99% |
Management effectiveness
| Return on assets (ttm) | 3.54% |
| Return on equity (ttm) | 12.06% |
Income statement
| Revenue (ttm) | 2.24B |
| Revenue per share (ttm) | 4.99 |
| Quarterly revenue growth (yoy) | -17.00% |
| Gross profit (ttm) | N/A |
| EBITDA | N/A |
| Net income avi to common (ttm) | 798.86M |
| Diluted EPS (ttm) | 1.78 |
| Quarterly earnings growth (yoy) | -98.60% |
Balance sheet
| Total cash (mrq) | 872M |
| Total cash per share (mrq) | 1.93 |
| Total debt (mrq) | 6.14B |
| Total debt/equity (mrq) | 62.24% |
| Current ratio (mrq) | 12.52 |
| Book value per share (mrq) | 14.41 |
Cash flow statement
| Operating cash flow (ttm) | 2.62B |
| Levered free cash flow (ttm) | -1.13B |
© 2024 Yahoo. All rights reserved.